How much does Chloroquine cost when there's no insurance? - in the UK

Panorama of the high pointic

Core active ingredient: chloroquine. It is commonly supplied as chloroquine phosphate, which contains a defined amount of chloroquine base per tablet.

Therapeutic class: antimalarial and antiprotozoal medication used historically for prevention and treatment of malaria where parasites remain sensitive. It is also used for certain extraintestinal protozoal infections.

Common UK strengths: 250 mg chloroquine phosphate tablets (approximately 155 mg chloroquine base) and occasionally 500 mg phosphate tablets (approximately 300 mg base).

Because Plasmodium falciparum resistance to chloroquine is widespread in many parts of the worldtake a moment to verify. destination-specific travel health guidance before relying on chloroquine for prophylaxis or therapy. For navigation within this page see the markers or take me to instructions for dosage.

Traces of activity

Chloroquine may be considered for:

• Treatment and weekly suppressive prevention of malaria due to Plasmodium vivax, P. ovale, P. malariae, and P. falciparum strains that are known to be chloroquine-susceptible.
• Treatment of extraintestinal amebiasis, usually in combination with a luminal agent to eradicate intestinal carriage.

Key caution: do not assume effectiveness against P. falciparum in areas with documented chloroquine resistance. Seek clarification from a professional NHS or specialist travel health guidance ensure setup before use.

Go back to the previous page atop | How chloroquine should be taken

Guidelines for taking chloroquine

• Take tablets with food or a milky drink to reduce stomach upset where possible.
• Follow the exact schedule prescribed by your clinician or pharmacist. Do not alter dose or duration without professional advice.
• For prophylaxis, continue for the full recommended period pre, during, and after travel. For treatment, complete the entire course even if symptoms improve.
• If you are on weekly dosing, choose one day of the week to take the tablet so you remember consistently.

What to do after missing your dose

If you do not take a dose take it as soon as you remember unless the next dose is due soon. Do not take two doses in one sitting to make up for a i skipped one dose. If in doubt, contact a pharmacist or prescriber.

Top of the page link | Go to dosage guidance

Dosage instructions

Dosing is frequently expressed in terms of chloroquine base. Useful conversions:

• 250 mg chloroquine phosphate approximately equals 155 mg chloroquine base.
• 500 mg chloroquine phosphate approximately equals 300 mg chloroquine base.

Paediatric dosing is weight based and should not exceed adult maximums. Adjustments may be required for renal or hepatic impairment.

Suppression of malaria via prophylactic treatment

Adults: 500 mg chloroquine phosphate (about 300 mg base) once weekly on the same day each week.

The junior generation: 5 mg/kg/week of chloroquine base, up to the adult weekly dose.

Timing: Start 1 to 2 weeks before entering the area of risk. If travel starts soon, an adult loading strategy may be given on day 1 as 1 g chloroquine phosphate (about 600 mg base) divided into two doses 6 hours apart; children receive an equivalent 10 mg base/kg split similarly. Continue weekly during exposure and for 4 to 8 weeks after leaving the endemic region according to current UK advice.

Ways to treat acute malaria (chloroquine-susceptible)

Adult example regimen (frequently used 3-day schedule):

• First dose on day 1: 1 g chloroquine phosphate (about 600 mg base).
• Six to eight hours later on day 1: 500 mg chloroquine phosphate (about 300 mg base).
• Day 2 and day 3: 500 mg chloroquine phosphate (about 300 mg base) once daily.

Total adult course usually equals 2.five grams or less of chloroquine phosphate (about 1)the base mass equals 5 g

Young children receive weight-based dosing (for example, initial 10 mg base/kg, then subsequent 5 mg base/kg doses) with adult maxima not to be exceeded.

For a drastic cure of P. vivax versus P. ovale add an 8-aminoquinoline such as primaquine or tafenoquine after confirming G6PD status to lower relapse risk.

Entamoeba histolytica infection outside the gut

Adult regimen example: 1 g chloroquine phosphate (about 600 mg base) daily for two days followed by 500 mg phosphate (about 300 mg base) once daily for at least 2 to 3 weeks, typically combined with an appropriate luminal amebicide for intestinal eradication.

Always follow the prescriber's regimen and local clinical backing and guidance. Get a second opinion a clinician for dose adjustments related to weight, liver or kidney problems, pregnancy, or medicines the act of interaction concerns.

Return to the summit | Go to safety tips

Safety notes

• Longer courses or high cumulative doses require periodic time sensitive monitoring, particularly retinal checks to detect early signs of ocular toxicity.
• Report visual changes at once: blurred or distorted vision, difficulty reading, altered colour perception, eye pain, or new loss of vision should prompt assessment by an eye specialist.
• Avoid driving or operating heavy machinery if you feel drowsy, dizzy, or experience visual disturbances until you know how the medicine affects you.
• Discuss alcohol, herbal products, supplements, and OTC medicines with a pharmacist to identify potential the study maps how the process of people engagings evolve over time..
• Pregnancy and breast feeding: chloroquine may be used when benefits outweigh risks; discuss with your clinician for individualized advice.
• Use caution if you have pre-existing retinal disease, significant liver or kidney impairment, seizure disorders, psoriasis, porphyria, or known QT prolongation, or if you take other medicines that affect the QT interval.
• Chloroquine can increase the effect of insulin and oral hypoglycaemic agents and may cause hypoglycaemia. Monitor blood glucose closely if you are on glucose-lowering treatment.

Contact your healthcare provider if harmful impacts develop or you are unsure about safety in your specific situation.

Return to the previous step top | Check for any plausible side effect risks

Possible outcomes affecting wellbeing

Adverse reactions are generally less frequent with short courses than with prolonged therapy. Rapidly seek medical help for severe reactions.

Symptoms requiring immediate attention

• Marked muscle weakness, sudden severe mood or behaviour changes, or unexplained severe urinary symptoms.
• Serious vision problems such as sudden loss of sight, severe blur, or eye pain.
• Neurological signs including seizures, new ringing in the ears, or hearing loss.
• Signs of bleeding or severe infection: unusual bruising, black stools, blood in urine or stools, ongoing fever, sore throat, or respiratory symptoms.
• Widespread rash accompanied by systemic symptoms or pinpoint red spots on the skin.

Commonly reported harmful impacts

• Nausea, vomiting, abdominal discomfort, or cramping.
• Headache disorder and transient blurred near vision or difficulty focusing.
• Itching or pruritus; frequency varies between populations.
• An episode of diarrhoea and decreased appetite.

Less usual effects

• Blue-black pigmentation of skin, nails, or oral mucosa in rare cases.
• Increased hair loss or hair colour changes.
• Cutaneous eruptiones of varying severity.

Traces of activity that someone has overdose deathd

• Excessive drowsiness or agitation and other central nervous system effects.

Remember that some eye effects may appear or progress after stopping the drug. If any new or persistent symptoms occur, consult a healthcare professional promptly.

Return to the context page top | Peruse the the exchange between peoples at scale reveal systemic patterns. now and cautions

Guidance on the mutual influence during contacts span conversations, gestures, and feedback. and cautions

• Antacids and certain adsorbents can reduce absorption; separate dosing by several hours when possible.
• Combining chloroquine with other medicines that prolong the QT interval can raise the risk of arrhythmia. Examples include some macrolide antibiotics, fluoroquinolones, some antipsychotics, and amiodarone. ECG assessment may be indicated for some patients.
• Insulin and oral hypoglycaemic drugs: chloroquine may enhance glucose-lowering effects and precipitate hypoglycaemia.
• Concomitant use with cyclosporine or digoxin may alter drug levels; metric monitoring may be required.
• Drugs that lower the seizure threshold, such as mefloquine, may increase seizure risk when used together in susceptible individuals.
• Cimetidine available as prescribed medication may reduce chloroquine clearance, while rifampicin can alter exposure. Review all prescription and non-prescription products with a pharmacist before starting chloroquine.

Return to where you left off the very top | Packing and advice for containers and shelves organize storage space effectively.

Guidelines for storing

• Keep at room temperature in a closed container away from moisture and direct light.
• Do not store in the freezer. Do not allow children to reach or observe this item.
• Dispose of expired or unwanted medicine in line with local guidance or return to the previous page to the previous state a pharmacy for safe disposal. Do not keep out-of-date drugs at home.

Return to the original page the summit of the page | Review the logs variant options

Other options plus analogous medicines

The optimal antimalarial depends on destination resistance patterns, patient medical history, age, pregnancy status, and tolerance. Typical option choices include:

• Atovaquone/proguanil (example brand Malarone): widely used for prevention and for treatment other possibilities in regions with chloroquine resistance.
• Doxycycline: used for prophylaxis in many areas with resistance; note the risk of photosensitivity.
• Mefloquine: weekly prophylaxis option but has potential neuropsychiatric negative outcomes in some patients.
• Artemisinin-based combination therapies (for example, artemether-lumefantrine): first-line treatments for uncomplicated falciparum malaria in many countries, not used for prophylaxis.
• Quinine, often combined with doxycycline or clindamycin, for resistant infections.
• Primaquine and tafenoquine for radical cure of P. vivax and P. ovale after confirming G6PD status; G6PD testing is mandatory prior to prescribing these agents.
• Hydroxychloroquine: related compound used mainly in rheumatology; it is not a guaranteed substitute for malaria prophylaxis where resistance exists.

For extraintestinal amebiasis, systemic drugs such as metronidazole or tinidazole are typically used along with a luminal agent like diloxanide furoate or paromomycin.

Consult with your advisor a travel clinic, pharmacist, or GP to select the most appropriate option for your trip and personal medical background.

Go to top | Average costs in the United Kingdom

Usual pricing options levels in the UK (guide in GBP)

Costs vary by supplier, pack size, brand, and whether the item is supplied through a private travel clinic or retail pharmacy. These are approximate recent retail ranges in the United Kingdom:

• Chloroquine phosphate 250 mg (example Avloclor) 20 tablets: around 8 to 12 pounds.
• Chloroquine phosphate 500 mg tablets, when available: roughly 10 to 20 pounds per 20 tablets.
• Doxycycline 100 mg courses for prophylaxis: typically 10 to 25 pounds depending on duration and supplier.
• Atovaquone/proguanil (adult strength): about 25 to 45 pounds for short trips; longer supplies cost more.
• Mefloquine (Lariam) 250 mg typical course: commonly 25 to 40 pounds.
• Artemether-lumefantrine (Riamet) treatment pack: about 30 to 60 pounds.
• Primaquine or tafenoquine: prices vary widely, often 20 to 60 pounds or more; G6PD testing may incur additional costs.

Note that routine antimalarial prophylaxis for travel is usually not funded by the NHS and is provided privately. Use UK-registered pharmacies or GPhC-registered online services that display the approved distance-selling logo to ensure quality and compliance. Obtain professional inputation and dispensing fees may apply.

Take me to the high point of the page | Status in law in the United Kingdom and access

Status under British access to law and legal remedies

• Regulatory bodies: the Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicinal products; the General Pharmaceutical Council (GPhC) regulates pharmacists and drugstore providers.
• Classification in the UK: some chloroquine products for prophylaxis are sold as Pharmacy medicines (P) and may be supplied by a pharmacist after an assessment; most treatment uses are Prescription Only Medicines (POM).
• Where to obtain: community pharmacies, private travel clinics, GPhC-registered online pharmacies, or via private prescription from a GP or travel clinic.
• Remote supply: reputable online services must carry out a structured clinical assessment and show UK registration and contact details. Verify registration if ordering online.
• Patient Group Directions and private prescribing: travel clinics may supply antimalarials under PGDs or provide private prescriptions following an assessment.
• NHS funding: routine travel prophylaxis is typically not provided on the NHS; expect to pay privately for medication and any clinic consultation.
• Advertising and importation: POMs may not be advertised to the public. Personal importation of prescription medicines is restricted; use UK suppliers to avoid legal and safety issues.
• Clinical advice: do not use chloroquine for travel to areas with known resistance unless advised by a clinician. Arrange a consultation guidance such as NHS Fit for Travel for destination-specific recommendations.

If you are unsure about lawful access to chloroquine in the UK or its suitability for your journey, speak to a UK pharmacist, GP, or an accredited travel health clinic.

Take me to the summit of the page